Teriparatide Superior to Risedronate in Reducing Fracture Risk in Older Women With Vertebral Fractures
By Chris Berrie…
dgnews.docguide.com
By Chris Berrie…
dgnews.docguide.com
FDA Approves Tymlos for Postmenopausal Osteoporosis
Radius Health, Inc., has announced that the US Food and Drug Administration (FDA) has approved Tymlos (abaloparatide) injection for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as history of osteoporotic fracture, multiple risk factors for fracture, or p…
mdedge.com
